• 한국물환경학회지
• /
• 제20권4호
• /
• pp.307-312
• /
• 2004

This study was focused on experiment for the separation and concentration process of Cu(II), Zn(II) solution with the variation of applied pressure and concentration using reverse osmosis plate and frame modules. Rejection coefficient and degree of concentration for Cu(II) component using single and multi-stage reverse osmosis process were showed 96.3~97.8%, 0.044~0.191(in single-stage), 96.3~98.4%, 0.400~2.264(in multi-stage) within the range of experimental condition, respectively. Those of Zn(II) were 93.3~97.1%, 0.019~0.395(in single-stage), 96.3~98.2%, 0.365~1.454(in multi-stage), respectively. Degree of concentration of multi-stage were higher than those of single-stage. Heavy metal[Cu(II), Zn(II)] separation was very efficient in using reverse osmosis plate and frame type modules. Separation efficiency for a mixed solution Cu(II) and Zn(II) was higher than those of each one of Cu(II) and Zn(II).

• 자원환경지질
• /
• 제30권3호
• /
• pp.197-207
• /
• 1997

Rocks in the Cheongsong mine area consist of Precambrian gneiss, Cretaceous sedimentry rocks and late Cretaceous quartz porphyry. The Cheongsong deposit is composed of many hydrothermal quartz veins of strikes $N30^{\circ}{\sim}60^{\circ}W$, dips $60{\sim}85^{\circ}E$ which fill WNW fault system. Pyrite and hematite occur within transparent quartz near margins of early stage II, and milky quartz of middle stage II coexists with sphalerite, chalcopyrite and galena coexisting with Cu-Pb-Bi minerals in center part of stage II quartz veins. Stage III calcite vein filled cracks or fractures of earlier quartz veins contains native copper and chalcopyrite. Supergene minerals are chalcocite, covellite, malanchite and chrysocolla. Alteration minerals are sericite, chlorite, argillite, epitode and pyrite. Ranges of salinities and homogenization temperatures for fluid inclusions in the individual periods of stage II are: 3.7 to 7.8 wt.% eq. NaCl and 200 to $380^{\circ}C$ in transparent quartz of early stage II; 0.7 to 6.4 wt.% eq. NaCl and 200 to $320^{\circ}C$ in milky quartz of middle stage II; 0.0 to 0.9 wt.% eq. NaCl and 250 to $320^{\circ}C$ in calcite of late stage II. Those of stage III calcite range about 0 wt.% eq. NaCl, and from 140 to $260^{\circ}C$, respectively. The relationship between salinities and temperatures shows decrease tendency with paragenetic time from stage II to III. The ${\delta}^{18}O_{H_2O}$ value is 0.5‰ in stage I, range from 0.5 to -0.4‰ in stage II, and from -3.2 to -3.7‰ in stage III. Calcite in the stage II and stage III has ${\delta}^{13}C$ values of -5.0‰ and -4.5 to -4.9‰, respectively. There is a decrease in sulfur fugacity values with paragenetic time of stage II, from $10^{-6.3}$ atm for early mineralization, to $10^{-6.5}$ atm for middle stage, to $10^{-8.0}$ atm for late mineralization of stage II. The results of stable isotope and fluid inclusion indicate that ore fluids reacted with meteoric water and wall rock in the Cheongsong hydrothermal system.

• 자원환경지질
• /
• 제21권3호
• /
• pp.257-268
• /
• 1988

The Mugeug gold deposits is consisted of more than fourteen gold and silver-bearing quartz veins emplaced in Mesozoic granodiorite mass. In the Samhyungje vein, one of the representative vein in the mine, six stages of mineralizatidns are recognized: Stage I, deposition of base-metal sulfides and gray quartz; stage II, deposition of base-metal sulfides, electrum and white quartz with pinkish tint; stage m, deposition of base-metal sulfides and dark gray quartz; stage N, deposition of native silver, argentite, Ag-tetrahedrite, polybasite, arsenpolybasite and quartz; stage V, deposition of nearly barren quartz; stage VI, deposition of transparent quartz veinlets with minor pyrite. Ag contents of electrum increase steadily from stage II to stage N; 57.25-61.44 atom. % for stage II, 62.85-69.66 atom. % for stage m, 69.79-74.12 atom. % for stage N. Homogenization temperatures of fluid inclusions are as follows; stage II, from $194^{\circ}$ to $287^{\circ}C$; stage V, from $137^{\circ}$ to $171^{\circ}C$, stage VI, from $192^{\circ}$ to $232^{\circ}C$. Salinities of fluid inclusions range from 3.7 to 7.9 wt.% equivalent NaCl in stage II and from 0.8 to 4.3 wt.% equivalent Nael in stage V. Ore mineralogy suggest that temperature and sulfur fugacity declined steadily from $290^{\circ}$ to $150^{\circ}C$ and from $10^{-10.5}$ to $10^{-19.0}$atm. through stage II into stage N. Fluid pressure during stage II inferred from data of mineral assemblages and fluid inclusions is 370bar.

• 대한두경부종양학회지
• /
• 제21권1호
• /
• pp.26-31
• /
• 2005

Backgrounds and Objectives: Squamous cell carcinomas of the oral cavity(SCOC) in TNM stage I & II have relatively high chance to be cured compared to those in the advanced stage, but sometimes result in the treatment failure with poor prognosis. There have been few reports on the patterns of failure and the clinical courses for SCOC in stage I & II after the failure of initial treatment. This study is directed at identifying the clinical outcomes of stage I & II SCOC and the salvage rate after initial treatment and suggesting an optimal level of treatment by analyzing the patterns of failure. Material and Methods: The medical records of 36 patients with SCOC, initially diagnosed between 1995 and 2001 as TNM stage I & II were reviewed retrospectively. The patterns of failure, salvage treatment, clinical courses, and the survival of these subjects were analyzed. The minimum follow-up period of no-evidence of disease(NED) was 12 months with an average of 32.2 months. Results: Overall rate of the treatment failure in SCOC of stage I & II was 41. 7%(15/36 cases). Most of the treatment failure in the subjects with stage I tumors occurred in regional lymph node. Local failure was the most frequent form of failure in the subjects with stage II tumors after wide excision of primary tumor with elective neck dissection and/or radiation therapy. No significant correlation was noted between the safety margin and the local failure. Elective neck dissections in stage I & II SCOC had a tendency to reduce regional failure (p=0.055). The salvage rates at 24 months were 85.7% in stage I, and 37.5% in stage II. The 3-year survival rate after the failure of initial treatment was 55.0%. Conclusion: SCOC of stage I & II after the failure of initial treatment showed poor prognosis despite of the salvage treatments. This study implies that the elective neck dissections for regional lymph node should be required for SCOC of stage I & II to reduce the treatment failure.

• 화훼연구
• /
• 제17권2호
• /
• pp.121-127
• /
• 2009

본 연구는 daminozide의 엽면 살포방법을 이용하여 국내 육성 스프레이 국화 '가마(Gama)'의 하계 고온에 의한 꽃목 길이의 과도한 신장을 억제함으로서 품질을 향상시키기 위해 수행하였다. 처리 시기는 화뢰 발달과 정별로 3단계(stage I, II, III)로 나누고 daminozide (DMZ)의 처리농도는 0, 500, 1000, $2000mg{\cdot}L^{-1}$로 구분하여 조합 처리하였다. 절화장과 꽃목 길이는 stage II에서 신장 억제효과가 가장 크게 나타났고, DMZ의 농도가 증가할수록 절화장과 꽃목 길이는 감소하였다. 줄기직경과 화폭은 무처리구에 비하여 처리시기가 늦어질수록 줄어들었으며, DMZ의 농도가 증가할수록 비례적으로 감소하였다. 선단부의 평행 배열된 화수는 시기별로는 stage I과 II에서 농도에서는 $500-1,000mg{\cdot}L^{-1}$ DMZ 처리에서 각각 가장 많았다. 전체 처리 중에서는 $1,000mg{\cdot}L^{-1}$ DMZ를 stage II에 처리시 무처리구 대비 24.2%가 증가하여 가장 우수하였다. 화수와 총 화뢰수도 $1,000mg{\cdot}L^{-1}$ DMZ를 stage II에 처리시 가장 많았다. '가마(Gama)'의 하계 재배시 꽃목(소화경)의 신장을 가장 효과적으로 억제하고 화서배열을 고르게 하며 화수 증가를 유도하는 DMZ의 처리농도와 시기는 $1,000mg{\cdot}L^{-1}$와 stage II로 나타났다. 그러나 이 처리는 절화장, 줄기직경, 화폭의 감소가 크게 나타나 상품성의 또 다른 면에서 불리하게 작용하였다. 따라서 실용적인 최적 처리시기와 농도는 stage I에서 $1,000mg{\cdot}L^{-1}$로 판단되었다.

• Journal of Chest Surgery
• /
• 제26권9호
• /
• pp.686-695
• /
• 1993

A total of eighty one patients with resected stage II and IIIA non-small cell lung cancer treated with postoperative adjuvant radiation therapy between Jan. 1971 and Dec. 1990 were retrospectively analysed to evaluate whether postoperative radiation therapy improves survival. Patterns of failure and prognostic factors were also analysed. The 5 year overall and disease free survival rate were 40.5%, 43.4% and median survival 30 months. The 5 year actuarial survival rates by stage II and IIIA were 53.9% and 36.2%. Loco-regional failure rate was 14.7% and distant metastasis rate was 33.3% and both 4%. Statistically significant prognostic factor affecting survival was presence of mediastinal lymph node metastasis[N2]. This retrospective study suggests that postoperative radiation therapy in resected stage II and IIIA non-small cell lung cancer can reduce loco-regional recurrence and may improve survival rate as compared with other studies which were treated by surgery alone.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권6호
• /
• pp.2413-2418
• /
• 2015

Background: Although adjuvant chemotherapy is a standard treatment in stage III colon cancer, its benefit is not as clear for stage II patients. In this retrospective analysis, we aimed to evaluate the survival of patients with low-risk stage II colon cancer, the efficacy of adjuvant chemotherapy in high-risk stage II colon cancer patients, and prognostic factors in stage II disease. Materials and Methods: One hundred and seventeen patients who were diagnosed with stage II colon cancer between January 2006 and December 2011 were included in the study. Patients were stratified into two groups as being low-risk and high-risk according to risk factors for stage II disease. Adjuvant 5-fluorouracil-based chemotherapy were administered to the patients with risk factors. Results: Ninety-four patients were treated with adjuvant chemotherapy due to high risk factors and 23 were monitored without treatment. Median follow-up time was 43 months. In terms of disease free survival and overall survival, adjuvant chemotherapy did not provide a statistically significant difference. Univariate analysis demonstrated that bowel obstruction was the major risk factor for shortened disease-free survival, while bowel perforation and perineural invasion were both negative prognostic factors for overall survival. Conclusions: The recommendation of adjuvant chemotherapy for stage II colon cancer is not clear. In our study, it was found that adjuvant chemotherapy did not contribute to survival in high-risk stage II patients. Due to the fact that prognosis of stage II patients is good, many more patients will be needed for statistically significant differences in survival. Adjuvant chemotherapy containing 5 fluorouracil is being used to high-risk stage II patients although it is not a standard treatment approach.

• Radiation Oncology Journal
• /
• 제15권2호
• /
• pp.129-136
• /
• 1997

목적 : 본병원에서 방사선 단독치료를 받은 자궁경부암 환자의 생존율 및 재발 양상을 분석 하고 이에대한 결과를 비교 분석함으로서 치료방법에 대한 평가를 하고자 하였다. 대상 및 방법 : 1987년 5월부터 1991년 12월까지 자궁경부암병기(FIGO) IB, II A, II B 로 근치목적의 방사선치료를 완료한 220명의 환자를 대상으로 후향적 분석을 시행하였다. 이중 병기 IB환자는 1995년에 개정된 FIGO 분류법에 의해서 분석당시 IB1과 IB2로 재분류를 시행하였다. 방사선치료는 외부방사선치료와 강내조사를 병용하였으며 방사선치료 후 6개월에서 국소종양의 치유여부를 판정하였다. 추적기간은 3개월에서 115개월까지 였으며 평균 62개월이었고 추적율은 $93.6\%$(206/220) 였다. 결과 : 병기별 5년 생존율은 IB1(N=50), IB2(N=15), II A(N=58), II B(N=97)에서 각각 $94\%,\;87\%,\;69\%,\;56\%$였다. 생존과 관계있는 예후인자로는 병기(p=0.00), 진단시 혈색소치(p=0.00), 진단시 종양표지자 수치(p=0.02), 종양의 크기(0.00), 골반단층촬영에서의 임파선전이(p=0.04) 등이 통계적인 유의수준을 보였으나 다요인 분석에서는 병기만이 유일하게 통계적인 유의수준의 차이를 보였다. 판정이 가능한 214명의 방사선치료에 따른 국소종양제어율은 $81\%$였으며, 병기별로보면, IBI, IB2, II A, II B 각각 $100\%,\;86.7\%,\;84.5\%,\;68.1\%$의 결과를 보였다. 치료 후 재발율은 $15.5\%$(27/174)였으며, 병기별로 보면 IBI, IB2, II A, II B 각각 $8\%,\;0\%,\;22.4\%,\;19.4\%$였다. 결론 :촌기 자궁경부암 환자의 치료결과는 이미 보고되어 있는 다른 결과와 비교시 비슷한 수준을 보이나 진행된 II B 환자에서는 낮은 생존율의 결과를 보이고 있으며 이에대한 원인분석과 치료방법의 개선이 필요하다 하겠다.

• 대한화학회지
• /
• 제12권2호
• /
• pp.47-50
• /
• 1968

Dowex $1{\times}4$ 陰이온 交煥樹指를 二段階(높이:下段 22cm, 上段 3cm, 直經 1.5cm)로 充塡하여 비스머스 金屬中에 들어있는 不純物인 Pb(II), Ag(I), Cu(II)를 7.5M 鹽酸으로, 그리고 Zn(II), Fe(III)를 0.5M 鹽酸으로 分離하고 上段에 남아있는 Te(IV)은 2M NaOH 용액으로 容出하고 아직도 上段에 남아있는 Au(III)는 樹脂를 태워서 分離하였다. 또 한가지 方法은 같은 樹脂를 10cm 높이로 一段階의 管에 充塡하여 0.5M 鹽酸으로 Pb(II), Ag(I), Cu(II), Fe(III), Zn(II)를 함께 容出하여 비스머스 中에서 分離하였다. 分離된 모든 不純物은 比色法으로 定量하였다.

• Communications for Statistical Applications and Methods
• /
• 제26권2호
• /
• pp.163-173
• /
• 2019

Simon's two-stage designs are frequently used in phase II single-arm trials for efficacy studies. A concern of safety studies is too many patients who experience an adverse event. We show that Simon's two-stage designs for efficacy studies can be similarly used to design a two-stage safety study by modifying some of the design parameters. Given the type I and II error rates and the proportion of adverse events experienced in the first stage cohort, we prescribe a procedure whether to terminate the trial or proceed with a stage 2 trial by recruiting additional patients. We study the relationship between a two-stage design with a safety endpoint and an efficacy endpoint as well as use simulation studies to ascertain their properties. We provide a real-life application and a free R package gen2stage to facilitate direct use of two-stage designs in a safety study.